These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 1782131
41. Fat-soluble vitamin assessment, deficiency and supplementation in infants with cholestasis. Mancell S, Islam M, Dhawan A, Whelan K. J Hum Nutr Diet; 2022 Apr; 35(2):273-279. PubMed ID: 34679231 [Abstract] [Full Text] [Related]
44. The risk of plasma vitamin A, C, E and D deficiency in patients with metabolic syndrome: A case-control study. Godala M, Materek-Kuśmierkiewicz I, Moczulski D, Rutkowski M, Szatko F, Gaszyńska E, Tokarski S, Kowalski J. Adv Clin Exp Med; 2017 Jul; 26(4):581-586. PubMed ID: 28691410 [Abstract] [Full Text] [Related]
49. The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis. Sikkens EC, Cahen DL, Koch AD, Braat H, Poley JW, Kuipers EJ, Bruno MJ. Pancreatology; 2013 Jul; 13(3):238-42. PubMed ID: 23719594 [Abstract] [Full Text] [Related]
50. Vitamin E intake, α-tocopherol levels and pulmonary function in children and adolescents with cystic fibrosis. Woestenenk JW, Broos N, Stellato RK, Arets HG, van der Ent CK, Houwen RH. Br J Nutr; 2015 Apr 14; 113(7):1096-101. PubMed ID: 25762411 [Abstract] [Full Text] [Related]
52. Evaluation of the efficiency of nanomicellar formulation of fat-soluble vitamins in patients with cystic fibrosis: the study protocol for a randomized controlled trial. Soleimanzadeh M, Talebi S, Jaafari MR, Sayedi SJ, Emadzadeh M, Kianifar HR. Trials; 2024 Jan 16; 25(1):60. PubMed ID: 38229125 [Abstract] [Full Text] [Related]
54. Hypocalcemia as the initial manifestation of occult cholestatic liver disease. Clark JH, Hudson SD. Clin Pediatr (Phila); 1992 Jul 16; 31(7):428-31. PubMed ID: 1617868 [No Abstract] [Full Text] [Related]
55. Compounding of vitamin A, D3, E and K3 supplements for cystic fibrosis patients: formulation and stability study. Huyghebaert N, De Beer J, Vervaet C, Remon JP. J Clin Pharm Ther; 2007 Oct 16; 32(5):489-96. PubMed ID: 17875116 [Abstract] [Full Text] [Related]
56. Impaired brainstem auditory evoked potentials in patients with cystic fibrosis. Vaisman N, Tabachnik E, Shahar E, Gilai A. Dev Med Child Neurol; 1996 Jan 16; 38(1):59-64. PubMed ID: 8606017 [Abstract] [Full Text] [Related]
57. Vitamin A intake and serum retinol levels in children and adolescents with cystic fibrosis. Woestenenk JW, Broos N, Stellato RK, Arets HG, van der Ent CK, Houwen RH. Clin Nutr; 2016 Jun 16; 35(3):654-9. PubMed ID: 25975494 [Abstract] [Full Text] [Related]
58. Vitamin E deficiency and neurologic disease in adults with cystic fibrosis. Sitrin MD, Lieberman F, Jensen WE, Noronha A, Milburn C, Addington W. Ann Intern Med; 1987 Jul 16; 107(1):51-4. PubMed ID: 3592448 [Abstract] [Full Text] [Related]
59. Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening. Koscik RL, Lai HJ, Laxova A, Zaremba KM, Kosorok MR, Douglas JA, Rock MJ, Splaingard ML, Farrell PM. J Pediatr; 2005 Sep 16; 147(3 Suppl):S51-6. PubMed ID: 16202783 [Abstract] [Full Text] [Related]
60. Vitamin E deficiency neuropathy in children with fat malabsorption. Studies in cystic fibrosis and chronic cholestasis. Sokol RJ, Butler-Simon N, Heubi JE, Iannaccone ST, McClung HJ, Accurso F, Hammond K, Heyman M, Sinatra F, Riely C. Ann N Y Acad Sci; 1989 Sep 16; 570():156-69. PubMed ID: 2629595 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]